BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27122239)

  • 1. Metallothionein MT2A A-5G Polymorphism as a Risk Factor for Chronic Kidney Disease and Diabetes: Cross-Sectional and Cohort Studies.
    Hattori Y; Naito M; Satoh M; Nakatochi M; Naito H; Kato M; Takagi S; Matsunaga T; Seiki T; Sasakabe T; Suma S; Kawai S; Okada R; Hishida A; Hamajima N; Wakai K
    Toxicol Sci; 2016 Jul; 152(1):181-93. PubMed ID: 27122239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of metallothionein 2A core promoter region single-nucleotide polymorphism on accumulation of toxic metals in sinonasal inverted papilloma tissues.
    Starska K; Bryś M; Forma E; Olszewski J; Pietkiewicz P; Lewy-Trenda I; Danilewicz M; Krześlak A
    Toxicol Appl Pharmacol; 2015 Jun; 285(3):187-97. PubMed ID: 25900616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential effect of metallothionein 2A -5A/G single nucleotide polymorphism on blood cadmium, lead, zinc and copper levels.
    Kayaaltı Z; Aliyev V; Söylemezoğlu T
    Toxicol Appl Pharmacol; 2011 Oct; 256(1):1-7. PubMed ID: 21767559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metallothionein core promoter region polymorphism on cadmium, zinc and copper levels in autopsy kidney tissues from a Turkish population.
    Kayaalti Z; Mergen G; Söylemezoğlu T
    Toxicol Appl Pharmacol; 2010 Jun; 245(2):252-5. PubMed ID: 20303360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of genes involved in lipid metabolism and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study.
    Hishida A; Wakai K; Naito M; Suma S; Sasakabe T; Hamajima N; Hosono S; Horita M; Turin TC; Suzuki S; Kairupan TS; Mikami H; Ohnaka K; Watanabe I; Uemura H; Kubo M; Tanaka H;
    Lipids Health Dis; 2014 Oct; 13():162. PubMed ID: 25311932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The -5 A/G single-nucleotide polymorphism in the core promoter region of MT2A and its effect on allele-specific gene expression and Cd, Zn and Cu levels in laryngeal cancer.
    Starska K; Krześlak A; Forma E; Olszewski J; Morawiec-Sztandera A; Aleksandrowicz P; Lewy-Trenda I; Bryś M
    Toxicol Appl Pharmacol; 2014 Oct; 280(2):256-63. PubMed ID: 25157674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.
    Spoto B; Mattace-Raso F; Sijbrands E; Leonardis D; Testa A; Pisano A; Pizzini P; Cutrupi S; Parlongo RM; D'Arrigo G; Tripepi G; Mallamaci F; Zoccali C
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):232-40. PubMed ID: 25492254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein 2A gene polymorphisms in relation to diseases and trace element levels in humans.
    Sekovanić A; Jurasović J; Piasek M
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):27-47. PubMed ID: 32597135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTHFR, MTR and MTRR polymorphisms and risk of chronic kidney disease in Japanese: cross-sectional data from the J-MICC Study.
    Hishida A; Okada R; Guang Y; Naito M; Wakai K; Hosono S; Nakamura K; Turin TC; Suzuki S; Niimura H; Mikami H; Otonari J; Kuriyama N; Katsuura S; Kubo M; Tanaka H; Hamajima N
    Int Urol Nephrol; 2013 Dec; 45(6):1613-20. PubMed ID: 23595572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metallothionein 1A rs8052394 polymorphism on lead, cadmium, zinc, and aluminum levels in factory workers.
    Singh P; Mitra P; Goyal T; Kumar PVK; Sharma S; Sharma P
    Toxicol Ind Health; 2020 Oct; 36(10):816-822. PubMed ID: 32816651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc.
    Giacconi R; Cipriano C; Muti E; Costarelli L; Maurizio C; Saba V; Gasparini N; Malavolta M; Mocchegiani E
    Biogerontology; 2005 Dec; 6(6):407-13. PubMed ID: 16518702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of heavy metals and their binding protein metallothionein in type 2 diabetics with kidney disease.
    Raudenska M; Dvorakova V; Pacal L; Chalasova K; Kratochvilova M; Gumulec J; Ruttkay-Nedecky B; Zitka O; Kankova K; Adam V; Masarik M
    J Biochem Mol Toxicol; 2017 Jun; 31(6):. PubMed ID: 28059470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer.
    Krześlak A; Forma E; Chwatko G; Jóźwiak P; Szymczyk A; Wilkosz J; Różański W; Bryś M
    Toxicol Appl Pharmacol; 2013 May; 268(3):278-85. PubMed ID: 23466427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of metallothionein 2A polymorphism on placental cadmium accumulation: Is metallothionein a modifiying factor in transfer of micronutrients to the fetus?
    Tekin D; Kayaaltı Z; Aliyev V; Söylemezoğlu T
    J Appl Toxicol; 2012 Apr; 32(4):270-5. PubMed ID: 21328412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polymorphism in metallothionein 1A (MT1A) is associated with cadmium-related excretion of urinary beta 2-microglobulin.
    Lei L; Chang X; Rentschler G; Tian L; Zhu G; Chen X; Jin T; Broberg K
    Toxicol Appl Pharmacol; 2012 Dec; 265(3):373-9. PubMed ID: 22995156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of metallothionein 2A polymorphism on lead metabolism: are pregnant women with a heterozygote genotype for metallothionein 2A polymorphism and their newborns at risk of having higher blood lead levels?
    Tekin D; Kayaaltı Z; Söylemezoğlu T
    Int Arch Occup Environ Health; 2012 Aug; 85(6):631-7. PubMed ID: 22005883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Klotho Gene Polymorphism and Markers of Bone Metabolism in Patients Receiving Maintenance Hemodialysis in Iran.
    Nazarian A; Hasankhani M; Aghajany-Nasab M; Monfared A
    Iran J Kidney Dis; 2017 Nov; 11(6):456-460. PubMed ID: 29190606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallothionein 2A genetic polymorphism and its correlation to coronary heart disease.
    Yang XY; Sun JH; Ke HY; Chen YJ; Xu M; Luo GH
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3747-53. PubMed ID: 25555862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a polymorphism of the interleukin 6 receptor gene with chronic kidney disease in Japanese individuals.
    Horibe H; Fujimaki T; Oguri M; Kato K; Matsuoka R; Abe S; Tokoro F; Arai M; Noda T; Watanabe S; Yamada Y
    Nephrology (Carlton); 2015 Apr; 20(4):273-8. PubMed ID: 25524550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of IL4-590C/T and IL6-174G/C Gene Polymorphisms in Type 2 Diabetic Patients With Chronic Kidney Disease in North Indian Population.
    Neelofar K; Ahmad J; Ahmad A; Alam K
    J Cell Biochem; 2017 Jul; 118(7):1803-1809. PubMed ID: 27996163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.